SATURDAY 21 JULY 2018
Today was the first of the two pre-conference days at the RAI Conference Centre in Amsterdam, before the official start of the 22nd International AIDS Conference (AIDS2018) on Monday evening.
‘HIV Cure Research with the Community’ is the theme of my session today; conducted as a workshop with some of the best and brightest HIV researchers and clinical scientists in the world. In attendance was a very special guest, Timothy Brown (AKA the Berlin Patient), who is the only person to have ever had HIV completely eradicated from his body.
With such an amazing list of speakers, what an inspiring first session to kick off the conference!
After short introductions and broad discussion of current HIV cure research, we formed small groups to brainstorm the elements we thought would form a path to a HIV cure. What were the driving aspects to a cure? What would a cure look like? The responses from the researchers and clinicians related mainly to the technical aspects of creating a cure. For the people living with HIV (PLHIV) in the group, responses related to the effects a cure would have on our daily lives.
Equality of access to treatments, affordable cures and vaccines, and fewer trips to the doctors rated highly with PLHIV in the room, while the technical specifications and barriers, such as a bio-marker for what demonstrates a cure, or the methods to eliminating ‘viral reservoirs’, were the focus of the researchers.
This simple exercise at the start of the day highlighted the sometimes vast and varying perspectives and expectations that occur between researchers, clinicians and those living with HIV, when discussing treatments and cures. The need to combine these perspectives is crucial. Indeed, the conference theme this year is “Breaking Barriers, Building Bridges”, and what better demonstration of the need to bridge both the research and the lived experience of HIV to end the epidemic.
While there was much said about the different methods to finding a cure, what I found most interesting was the suggestion that there may soon be more individuals already identified as having eradicated HIV from their bodies. Certain studies monitoring hundreds of PLHIV showed a few rare instances of long lasting viral suppression, and therefore perhaps more cures, but it was too early to know for sure and no such declarations were ready to be made by those researchers in the room.
The timing of treatment commencement, a person’s immune system and a number of other factors seem to be required to align for such (potential) cures to take place. While those stars don’t align for most PLHIV at this stage this is very encouraging news.
Timothy Brown’s experience back in 2008 had opened a range of HIV elimination possibilities that many researchers had never thought possible, and recent studies could very well be the catalysts to understanding the next steps in the pursuit of a cure for all.
It’s certainly very exciting to be here in Amsterdam.